INNATE PHARMA S A's ticker is IPHA and the CUSIP is 45781K204. A total of 14 filers reported holding INNATE PHARMA S A in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $113,734 | -21.4% | 44,954 | -4.5% | 0.00% | – |
| Q2 2023 | $144,676 | +4.2% | 47,049 | -3.4% | 0.00% | – |
| Q1 2023 | $138,858 | -24.6% | 48,722 | -1.3% | 0.00% | – |
| Q4 2022 | $184,138 | +61.5% | 49,367 | -13.2% | 0.00% | – |
| Q3 2022 | $114,000 | -9.5% | 56,852 | +22.0% | 0.00% | – |
| Q2 2022 | $126,000 | -16.6% | 46,598 | +3.7% | 0.00% | – |
| Q1 2022 | $151,000 | -16.1% | 44,954 | +14.3% | 0.00% | – |
| Q4 2021 | $180,000 | +65.1% | 39,330 | +121.8% | 0.00% | – |
| Q3 2021 | $109,000 | -9.9% | 17,729 | -51.6% | 0.00% | – |
| Q2 2021 | $121,000 | -50.0% | 36,630 | -34.7% | 0.00% | – |
| Q1 2021 | $242,000 | +1052.4% | 56,110 | +993.8% | 0.00% | – |
| Q4 2020 | $21,000 | +250.0% | 5,130 | +226.5% | 0.00% | – |
| Q3 2020 | $6,000 | -92.9% | 1,571 | -87.4% | 0.00% | – |
| Q2 2020 | $85,000 | +286.4% | 12,441 | +277.0% | 0.00% | – |
| Q1 2020 | $22,000 | – | 3,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BANK OF AMERICA CORP /DE/ | 46,749 | $133,235 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 61,899 | $176 | 0.00% |
| MORGAN STANLEY | 48,722 | $138,858 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 13,315 | $37,815 | 0.00% |
| Steward Partners Investment Advisory, LLC | 500 | $1,425 | 0.00% |
| Optiver Holding B.V. | 224,097 | $636,435 | 0.00% |
| BARCLAYS PLC | 412 | $1 | 0.00% |
| ROYAL BANK OF CANADA | 124 | $0 | 0.00% |
| UBS Group AG | 1,259 | $3,588 | 0.00% |